CellBio  Vol.3 No.2 , June 2014
In-Vitro Effect of Sex Steroids on Mouse Melanoma (B16F10) Cell Growth
Abstract: A battery of sex steroids were used to check their effect on mouse melanoma (B16F10) cell growth in-vitro. Progesterone and its synthetic receptor antagonist RU-486 showed maximum inhibition on in-vitro melanoma cell growth [1]. Further research work showed that the inhibition by progesterone was not a toxic, spurious or non-specific effect on mouse melanoma cell growth and the inhibition by progesterone was not mediated through progesterone receptor.
Cite this paper: Ramaraj, P. and Cox, J. (2014) In-Vitro Effect of Sex Steroids on Mouse Melanoma (B16F10) Cell Growth. CellBio, 3, 60-71. doi: 10.4236/cellbio.2014.32007.

[1]   Ramaraj, P. and Cox, J.L. (2011) Effect of Steroids on in-Vitro Melanoma Cell Growth and Viability. Endocrine Reviews, 12, 1-29 (Abstract).

[2]   Zouboulis, C.C. (2004) The Human Skin as a Hormone Target and an Endocrine Gland. Hormones, 3, 9-26.

[3]   Zouboulis, C.C., Chen, W.C., Thornton, M.J., Qin, K. and Rosenfield, R. (2007) Sexual Hormones in Human Skin. Hormone and Metabolic Research, 39, 85-95.

[4]   Gray-Schopfer, V., Wellbrock, C. and Marais, R. (2007) Melanoma Biology and New Targeted Therapy. Nature, 445, 851-857.

[5]   White, L.P. (1959) Studies on Melanoma-II Sex and Survival in Human Melanoma. New England Journal of Medicine, 260, 789-797.

[6]   Bodenham, D.C. and Hale, B. (1972) Malignant Melanoma, Endocrine Therapy in Malignant Disease. In: Stoll, B.A., Ed., W.B. Saunders Co. Ltd., London, 377-383.

[7]   Neifeld, J.P. and Lippman, M.E. (1980) Steroid Hormone Receptors and Melanoma. Journal of Investigative Dermatology, 74, 379-381.

[8]   Zhao, Y., Deng, C., Lu, W., Xiao, J., Ma, D., Guo, M., Recker, R.R., Gatalica, Z., Wang, Z. and Xiao, G.G. (2011) Let-7 microRNAs Induce Tamoxifen Sensitivity by Downregulation of Estrogen Receptor-α Signaling in Breast Cancer. Molecular Medicine, 17, 1233-1241.

[9]   Liu, T., Chen, L., Sun, X., Wang, Y., Li, S., Yin, X., Wang, X., Ding, C., Li, H. and Di, W. (2014) Progesterone Receptor PROGINS and +331G/A Polymorphisms with Ovarian Cancer Susceptibility to Ovarian Cancer: A Meta-Analysis Based on 17 Studies. Tumor Biology, 35, 2427-2436.

[10]   Ming, D.S., Pham, S., Deb, S., Chin, M.Y., Kharmate, G., Adomat, H., Beheshti, E.H., Locke, J. and Guns, E.T. (2014) Pomegranate Extracts Impact the Androgen Biosynthesis Pathways in Prostate Cancer Models in Vitro and in Vivo. The Journal of Steroid Biochemistry and Molecular Biology, 143C, 19-28.

[11]   Mather, J.P. and Sato, G.H. (1979) The Growth of Mouse Melanoma Cells in Hormone-Supplemented, Serum-Free Medium. Experimental Cell Research, 120, 191-200.

[12]   Pavelic, K., Petrusic, L., Osmak, M. and Culo, F. (1983) In Vivo and in Vitro Effect of Progesterone on the Growth of Some Mouse and Human Tumors. Research in Experimental Medicine, 183, 183-191.

[13]   Kanda, N. and Watanabe, S. (2001) 17β-Estradiol, Progesterone and Dihydrotestosterone Suppress the Growth of Human Melanoma by Inhibiting Interleukin-8 Production. Journal of Investigative Dermatology, 117, 274-283.

[14]   Ranson, M., Posen, S. and Mason, R.S. (1988) Human Melanocytes as a Target Tissue for Hormones: In Vitro Studies with 1α-25 Dihydroxy Vitamin D3, α-Melanocyte Stimulating Hormone and β-Estradiol. Journal of Investigative Dermatology, 91, 593-598.

[15]   Cos, S., Garcia-Bolado, A. and Sanchez-Barcelo, E.J. (2001) Direct Antiproliferative Effects of Melatonin on Two Metastatic Cell Sub-Lines of Mouse Melanoma (B16BL6 and PG19). Melanoma Research, 11, 197-201.

[16]   Denzit, F. and Lang, R. (1986) Rapid Colorimetric Assay for Cell Growth and Survival, Modifications to the Tetrazolium Dye Procedure Giving Improved Sensitivity and Reliability. Journal of Immunological Methods, 89, 271-277.

[17]   Brown, C., Pan, X. and Hassid, A. (1999) Nitric Oxide and C-Type Atrial Natriuretic Peptide Stimulate Primary Aortic Smooth Muscle Cell Migration via a cGMP-Dependent Mechanism: Relationship to Microfilament Dissociation and Altered cell Morphology. Circulation Research, 84, 655-667.

[18]   Bhakoo, H.S., Paolini, N.S., Milholland, R.J., Lopez, R.E. and Rosen, F. (1981) Glucocorticoid Receptors and the Effect of Glucocorticoids on the Growth of B16 Melanoma. Cancer Research, 41, 1695-1701.

[19]   Crowley, P., Lai, N.Y., De Young, N., Pearce, P., Funder, J.W. and Gill, P.G. (1998) Inhibition of Growth of B16 Melanoma by Glucocorticoids Does Not Result Directly from Receptor Mediated Inhibition of Tumor Cells. Oncology, 45, 331-335.

[20]   Dhatariya, K.K. and Nair, K.S. (2003) Dehydroepiandrosterone: Is There a Role for Replacement? Mayo Clinic Proceedings, 78, 1257-1273.

[21]   Kemeny, M.M., Busch, E., Stewart, A.K. and Menck, H.R. (1998) Superior Survival of Young Women with Malignant Melanoma. The American Journal of Surgery, 175, 437-445.

[22]   Richardson, B., Price, A., Wagner, M., Williams, V., Lorigan, P., Browne, S., Miller, J.G. and Mac Neil, S. (1999) Investigation of Female Survival Benefit in Metastatic Melanoma. British Journal of Cancer, 80, 2025-2033.

[23]   Duncan, L.M., Travers, R.L., Koerner, F.C., et al. (1994) Estrogen and Progesterone Receptor Analysis in Pregnancy-Associated Melanoma: Absence of Immunohistochemically Detectable Hormone Receptors. Human Pathology, 25, 36-41.

[24]   Neifeld, J.P. and Lippman, M.E. (1976) Fisher RI: Receptors for Steroid Hormones in Human Melanoma. Surgical Forum, 27, 108-110.

[25]   Markland, F.S. and Horn, D. (1980) Steroid Hormone Receptor Studies in Melanoma Model Systems. Journal of Supramolecular Structure, 13, 35-46.

[26]   Atif, F., Sayeed, I., Yousuf, S., Ishrat, T., Hua, F., Wang, J., Brat, D.J. and Stein, D.G. (2011) Progesterone Inhibits the Growth of Human Neuroblastoma: In Vitro and in Vivo Evidence. Molecular Medicine, 17, 1084-1094.

[27]   Fjelldal, R., Moe, B.T., Orbo, A. and Sayer, C. (2010) MCF-7 Cell Apoptosis and Cell Cycle Arrest: Non-Genomic Effects of Progesterone and Mifepristone (RU-486). Anticancer Research, 30, 4835-4840.